Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10

1.

Phenotype switch in acute lymphoblastic leukaemia associated with 3 years of persistent CAR T cell directed-CD19 selective pressure.

Lucero OM, Parker K, Funk T, Dunlap J, Press R, Gardner RA, Chang BH.

Br J Haematol. 2019 Feb 27. doi: 10.1111/bjh.15812. [Epub ahead of print] No abstract available.

PMID:
30810217
2.

Keratinocyte carcinomas arising near arteriovenous fistulas: Case series and safety considerations for dermatologic surgery: A report of the International Transplant Skin Cancer Collaborative.

Lucero OM, Echaiz CF, Jafarian F, Fox MC, Vetto JT, Mueller RV, Teixeira PG, Zwald FO, Leitenberger JJ.

JAAD Case Rep. 2018 Dec 4;5(1):7-11. doi: 10.1016/j.jdcr.2018.08.021. eCollection 2019 Jan. No abstract available.

3.

Quinacrine-Associated Punctate Palmar Keratoderma.

Haag C, Lucero OM, Fett NM.

J Clin Rheumatol. 2018 Jun 29. doi: 10.1097/RHU.0000000000000849. [Epub ahead of print] No abstract available.

PMID:
29965855
4.

A case illustrating successful eradication of recurrent, aggressive basal cell carcinoma located in a scar with vismodegib.

Lucero OM, Fitzmaurice S, Thompson C, Leitenberge J.

Dermatol Online J. 2018 Feb 15;24(2). pii: 13030/qt92k2f96t.

5.

Dysregulation of inflammatory gene expression in lesional and nonlesional skin of patients with pyoderma gangrenosum.

Ortega-Loayza AG, Nugent WH, Lucero OM, Washington SL, Nunley JR, Walsh SW.

Br J Dermatol. 2018 Jan;178(1):e35-e36. doi: 10.1111/bjd.15837. Epub 2017 Dec 5. No abstract available.

PMID:
28734003
6.

Identification, genetic testing, and management of hereditary melanoma.

Leachman SA, Lucero OM, Sampson JE, Cassidy P, Bruno W, Queirolo P, Ghiorzo P.

Cancer Metastasis Rev. 2017 Mar;36(1):77-90. doi: 10.1007/s10555-017-9661-5.

7.

WNT5A enhances resistance of melanoma cells to targeted BRAF inhibitors.

Anastas JN, Kulikauskas RM, Tamir T, Rizos H, Long GV, von Euw EM, Yang PT, Chen HW, Haydu L, Toroni RA, Lucero OM, Chien AJ, Moon RT.

J Clin Invest. 2014 Jul;124(7):2877-90. doi: 10.1172/JCI70156. Epub 2014 May 27.

8.

Wnt/β-catenin signaling and AXIN1 regulate apoptosis triggered by inhibition of the mutant kinase BRAFV600E in human melanoma.

Biechele TL, Kulikauskas RM, Toroni RA, Lucero OM, Swift RD, James RG, Robin NC, Dawson DW, Moon RT, Chien AJ.

Sci Signal. 2012 Jan 10;5(206):ra3. doi: 10.1126/scisignal.2002274.

9.

A re-evaluation of the "oncogenic" nature of Wnt/beta-catenin signaling in melanoma and other cancers.

Lucero OM, Dawson DW, Moon RT, Chien AJ.

Curr Oncol Rep. 2010 Sep;12(5):314-8. doi: 10.1007/s11912-010-0114-3. Review.

10.

The V-ATPase B1-subunit promoter drives expression of Cre recombinase in intercalated cells of the kidney.

Miller RL, Lucero OM, Riemondy KA, Baumgartner BK, Brown D, Breton S, Nelson RD.

Kidney Int. 2009 Feb;75(4):435-9. doi: 10.1038/ki.2008.569. Epub 2008 Dec 3.

Supplemental Content

Loading ...
Support Center